|
|
|
Weekly Market: Impressive Week: Indices register 2.5% gain on RBI move
|
|
Saturday, January 17, 2015 |
| | | Market Commentary | | | Impressive Week: Indices register 2.5% gain on RBI move | | Indian stock markets closed the week on a strong note led by supportive domestic cues after central bank gave a surprise rate cut.. | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Friday, January 16, 2015 where key benchmark indices registered impressive gains in the week ended Friday, 16 January 2015, mainly on the back of sharp rally in the indices in the penultimate trading session of the week on Thursday, 15 January 2015, triggered by the Reserve Bank of India's (RBI) surprise announcement of a cut in its main lending rate viz. the repo rate by 25 basis points in an unscheduled monetary policy review on that day. The Sensex gained in three out of five trading sessions in the week.
The S&P BSE Sensex advanced 663.51 points or 2.41% to settle at 28,121.89. The CNX Nifty rose 229.30 points or 2.76% to settle at 8,513.80.
The BSE Mid-Cap index rose 207.10 points or 1.98% to settle at 10,633.11. The BSE Small-Cap index advanced 111.59 points or 0.99% to settle at 11,309.93. Both these indices underperformed the Sensex.
Weekly market trend from January 12 - January 16:
January 12- Key indices edged higher on Monday, as a drop in US wages last month spurred speculation the US Federal Reserve will delay an increase in interest rates. The Sensex advanced 126.89 points or 0.46% to settle at 27,585.27, its highest closing level since 5 January 2015.
January 13- Weakness during the latter part of the trading session pulled key benchmark indices lower on Tuesday. The Sensex declined 159.64 points or 0.58% to settle at 27,425.73, its lowest closing level since 8 January 2015.
January 14- After seeing high intraday volatility, key benchmark indices registered modest losses on Wednesday. The Sensex shed 78.91 points or 0.29% to settle at 27,346.82, its lowest closing level since 8 January 2015.
January 15- Key equity benchmark indices surged on Thursday, 15 January 2015, after the Reserve Bank of India's (RBI) surprise announcement of a cut in its main lending rate. The Sensex advanced 728.73 points or 2.66% to settle at 28,075.55, its highest closing level since 8 December 2014.
 January 16- Amid divergent trend among the various index components, key equity indices eked out small gains on Friday. The Sensex advanced 46.34 points or 0.17% to settle at 28,121.89, its highest closing level since 5 December 2014.
Global indices:
Global Indices closed mixed for the week where Dax 100 up 5.38%, CAC 40 rose 4.80% and Shanghai Composite was up by 2.77%. Top Losers: Nikkei down 1.94%, Nasdaq down 1.48% and Dow Jones slipped 1.27%
 Sectoral and stock screening:
Top gainers: S&P BSE Realty up 5.74%, S&P BSE CG up 4.77% and S&P BSE Power up 3.47%
| | Looking at the 'A' group stocks, the top three gainers of the week were - India Cements up by 21.82%, Sun TV up by 18.16% and HDIL up by 18.15%
Top three losers of the week were - Videocon Industries down by 12.95%, Hindalco down by 10.68% and FSL down by 9.51%. FII/MF activity:
The foreign institutional investors (FIIs) have been the net buyers of the Indian stocks to the tune of Rs2183.13 crore and the domestic investors bought Indian shares worth a net of Rs490.30 crore as on January 15, 2015. | | TOP MOVERS (GROUP A) |  | | | | | | | | India Cements | 102.15 | 21.82 | | | | | | | | | Videocon Industries | 166.40 | -12.95 | | | | | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 20,002.21 | 3,668.70 | | | Gross sale | 17,819.08 | 3,178.40 | | | Net investment | 2,183.13 | 490.30 | | | | | | | | | Data as on January 15, 2015 | | | | Market Outlook for the coming week!
In the coming week, corporate earnings of India Inc. and outcome of monetary policy meeting of European Central Bank scheduled next week will hold key triggers for domestic markets in the week ahead.
Meanwhile, investment by foreign portfolio investors (FPIs), the movement of rupee against the dollar and crude oil price movement will dictate the trend on the bourses in the forthcoming week.
On global front, the European Central Bank (ECB) meets next week amid speculation it will widen an asset-purchase program on increased concern over the possibility of deflation in the region. ECB meeting is scheduled on Thursday, 22 January 2015, when officials will consider a quantitative-easing package that will probably include buying government bonds.
Among other prominent data, China's October-December 2014 gross domestic data (GDP) is scheduled on Tuesday, 20 January 2015. Also, HSBC's China flash Manufacturing PMI for January is set to be released on Friday, 23 January 2015. The Bank of Japan's monetary policy meeting takes place on Wednesday, 21 January 2015. | | | | To know more about our products and services, click here. |  | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Fax: 67481899; E-mail: publishing@sharekhan.com; Website: www.sharekhan.com; CIN: U99999MH1995PLC087498. Sharekhan Ltd.: SEBI Regn. Nos. BSE- INB/INF011073351 ; CD-INE011073351; NSE- INB/INF231073330 ; CD-INE231073330; MCX Stock Exchange- INB/INF261073333 ; CD-INE261073330; DP-NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com
Contact: myaccount@sharekhan.com | | | |
|
posted by Anonymous @ 4:14 AM  |
|
|
|
|
|
